ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

Buy to open the SPDR S&P 500 ETF (SPY) June 235 put option. Our stock indicator is still firmly in "-2" territory. President Trump will speak before Congress tonight against high market expectations, and he may disappoint. We like the SPY June 235 put option. Read More

Shares of Argos Therapeutics (NSDQ: ARGS), a development stage biotech company for personalized cancer treatments, fell sharply Feb. 22 after the company announced it would halt its phase 3 trial of its Rocapuldencel-T drug in combination with Sunitinib for treating metastatic renal cell carcinoma (kidney cancer) in children. Unfortunately, the… Read More

Today the Fed released the minutes from its last Federal Open Market Committee (FOMC) meeting held on January 31 and February 1. The details of the meeting show that the committee members leaned toward raising interest rates again “fairly soon” if upcoming jobs and inflation data are in tune with… Read More

Sell Kindred Biosciences (KIN); Buy AAR Corp (AIR). The Oracle of Omaha Seth Klarman has reported that he sold his entire position in Kindred Biosciences (KIN). Following our mission, we likewise say goodbye to the stock. In its place, we add to our portfolio… Read More

Average Annualized Return Per Closed Trade: 20.6% Average Return Per Closed Trade: 17.0% Average Holding Period: 306 days The new Trump administration has had an up and down week. Highlights included the requested, tendered and accepted resignation of National Security Advisor Gen. Michael Flynn, the offer and refusal… Read More